This Article Full Text Full Text (PDF) All Versions of this Article: 111/21/2734    most recent CIRCULATIONAHA.104.497594v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raj, S. R. Articles by Robertson, D. Search for Related Content PubMed PubMed Citation Articles by Raj, S. R. Articles by Robertson, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PYRIDOSTIGMINE BROMIDE Related Collections Clinical Studies Arrhythmias, clinical electrophysiology, drugs Cardiovascular Pharmacology

(Circulation. 2005;111:2734-2740.)
© 2005 American Heart Association, Inc.

Arrhythmia/Electrophysiology

Acetylcholinesterase Inhibition Improves Tachycardia in Postural Tachycardia Syndrome

Satish R. Raj, MD; Bonnie K. Black, RN, NP; Italo Biaggioni, MD; Paul A. Harris, PhD; David Robertson, MD

From the Autonomic Dysfunction Center, Divisions of Clinical Pharmacology (S.R.R., I.B., D.R.) and Cardiovascular Medicine (B.K.B.), Departments of Medicine, Pharmacology (S.R.R., I.B., D.R.), Neurology (D.R.), and Biomedical Engineering (P.A.H.), Vanderbilt University, Nashville, Tenn.

Reprint requests to Satish R. Raj, MD, AA3228 Medical Center North, Vanderbilt University, 1161 21st Ave South, Nashville, TN 37232-2195. E-mail satish.raj{at}vanderbilt.edu

Received August 4, 2004; revision received February 7, 2005; accepted February 16, 2005.

Background— Postural tachycardia syndrome (POTS) induces disabling chronic orthostatic intolerance notable for an excessive increase in heart rate that occurs on standing. Many current therapeutic strategies focus on sympatholysis, but the alternative strategy of enhancing cardiovagal tone has not been studied. The objective of this study was to test the hypothesis that acetylcholinesterase inhibitors will attenuate the tachycardia and improve symptom burden in patients with POTS.

Methods and Results— Seventeen patients with POTS underwent acute drug trials of pyridostigmine 30 mg orally and placebo, on separate mornings, in a randomized crossover design. Blood pressures, heart rate, and symptoms were assessed while patients were seated and after they had been standing for up to 10 minutes both before the study drug was given and at 2 and 4 hours after study drug. The heart rate was significantly lower at 2 hours after pyridostigmine than after placebo (100±16 versus 111±14 bpm, P=0.001). Pyridostigmine significantly decreased the standing heart rate from baseline (119±16 bpm) at 2 hours (104±16 bpm, P<0.001) and 4 hours (100±16 bpm, P<0.001) after administration. There was no significant change in blood pressure. The decrease in symptom burden within 4 hours after study drug was significantly greater with pyridostigmine than placebo (–10.4±14.0 AU versus 0.6±7.5 AU, P<0.025).

Conclusions— Acute acetylcholinesterase inhibition significantly attenuated tachycardia in POTS. There was also an improvement in symptom burden with this promising therapy.

Key Words: tachycardia • acetylcholine • nervous system, autonomic • drugs • patients

This article has been cited by other articles:

				B. P. Grubb Postural Tachycardia Syndrome Circulation, May 27, 2008; 117(21): 2814 - 2817. [Full Text] [PDF]

				S. Vernino, P. Sandroni, W. Singer, and P. A. Low Invited Article: Autonomic ganglia: Target and novel therapeutic tool Neurology, May 13, 2008; 70(20): 1926 - 1932. [Abstract] [Full Text] [PDF]

				E. M. Garland, S. R. Raj, B. K. Black, P. A. Harris, and D. Robertson The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome Neurology, August 21, 2007; 69(8): 790 - 798. [Abstract] [Full Text] [PDF]

				A K Agarwal, R Garg, A Ritch, and P Sarkar Postural orthostatic tachycardia syndrome Postgrad. Med. J., July 1, 2007; 83(981): 478 - 480. [Abstract] [Full Text] [PDF]

				G. Filler, R. M. Gow, R. Nadarajah, P. Jacob, G. Johnson, Y.-L. Zhang, and U. Christians Pharmacokinetics of Pyridostigmine in a Child With Postural Tachycardia Syndrome Pediatrics, November 1, 2006; 118(5): e1563 - e1568. [Abstract] [Full Text] [PDF]